<DOC>
	<DOCNO>NCT00561067</DOCNO>
	<brief_summary>The purpose study evaluate tolerability efficacy erythropoietin ( EPO ) treatment spinal shock comparison methylprednisolone treatment ( MP ) .</brief_summary>
	<brief_title>Evaluation Tolerability Efficacy Erythropoietin ( EPO ) Treatment Spinal Shock : Comparative Study Versus Methylprednisolone ( MP )</brief_title>
	<detailed_description>Traumatic spinal cord injury ( TSCI ) devastate patient costly society . Currently , methylprednisolone ( MP ) administer accord NASCIS ( III ) protocol therapy minor benefit accompany dangerous side effect . Any new treatment TSCI allow major recovery function would significant advance clinical care . Much motor sensory paralysis follow TSCI occur delay widespread oligodendrocyte apoptosis demyelination long spinal tract . We recently report erythropoietin ( EPO ) administration significantly attenuate delayed secondary degeneration promote functional recovery TSCI animal model . The research propose multicenter trial involve Italian Spinal Units develop multidisciplinary experience management TSCI . Primary objective study assess superiority EPO compare MP improve clinical outcome SCI ( ASIA Impairment Scale ) ; secondary objective : ass safety EPO compare MP , effect motor sensory function improve functional autonomy , influence spasticity neurogenic pain , , impact surrogate end-points ( Somatosensory Evoked Potentials Magnetic Resonance Imaging ) .The study population characterize patient TSCI ( ASIA Impairment Scale A B ) admit Italian Spinal Units : estimate enrolment 100 subject , 50 therapeutic arm . The study propose single-blind randomized phase III parallel group trial eligible patient randomize one follow treatment modality : MP accord NASCIS III protocol EPO iv ( 500 UI/kg within 8 hour SCI , dosage repeat 24 48 hour ) . The duration study 24 month , 21-month maximum time engage patient require power calculation.The primary end-point assess use Cochrane-Mantel-Haenzel test ; change SEP ( latency ) size MRI lesion use Repeated Measures Analysis Variance ( ANOVA ) , Ashworth , VAS , PENN , SCIM score parametric Wilcoxon 's signed-ranks test . The effect treatment primary end-point evaluate use multivariate analysis model ( binary logistic regression ) . The non-parametric alternative conduct assumption normality verify .</detailed_description>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Traumatic SCI occur within 8 hour Hemodynamic stability time treatment start ( systolic blood pressure &gt; 90 mmHg least 1 hour without massive infusion vasopressor support ongoing bleeding ) Neurological level C5 T12 ( ASIA scale ) ASIA Impairment Scale : A B Informed consent SCI traumatic SCI cause edged weapon fire arm Traumatic SCI 8 hour Neurological level C5 T12 ASIA Impairment Scale C , D , E Uncontrolled arterial hypertension Past current cerebrovascular disease Past current acute myocardial infarction History thrombotic event Other chronic cardiovascular disorder ( cardiac arrhythmia , congestive heart failure ) History peripheral arterial disease , polycythemia , porphyria , active malignancy Previous current neurological disease abnormal neurological examination Suspected definite pregnancy lactation ( require ÃŸHCG confirmation ) Clinically relevant psychiatric disease Known allergy EPO Hypersensitivity human albumin Acute chronic renal failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Spinal cord injury</keyword>
	<keyword>spinal shock</keyword>
	<keyword>erythropoietin</keyword>
</DOC>